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The dynamics of skin-draining cells following infection or vaccination provide important 
insight into the initiation of immune responses. In this study, the local recruitment 
and activation of immune cells in draining lymph nodes (LNs) was studied in calves 
in an  adjuvant-induced inflammation. A transient but remarkably strong recruitment 
of monocytes was demonstrated after onset of inflammation, constituting up to 41% 
of live cells in the draining LNs after 24  h. Numerous CD14+ cells were visualized 
in subcutaneous tissues and draining LNs, and the majority of these cells did not 
express dendritic cell- associated markers CD205 and CD11c. In the LNs, recruited 
cells were predominately of a CD14++ and CD16+ phenotype, consistent with an 
intermediate monocyte subset characterized to possess a high inflammatory potential. 
Moreover, monocytes from the draining LN showed a high expression of genes coding 
for pro-inflammatory cytokines, including IL-1β, IL-6, TNFa, and TGFβ. Shortly after 
their appearance in the LN cortical areas, the monocytes had moved into the medulla 
followed by an increase in peripheral blood. In conclusion, this study provides novel 
information on in vivo monocyte recruitment and migration after onset of inflammation.
Keywords: monocytes, inflammation, lymph node, migration, pro-inflammatory cytokines
inTrODUcTiOn
A protective immune response to infection or vaccination is dependent on the recruitment of 
immune cells to the inflamed tissue, followed by their activation and the subsequent movement 
of cells and antigens to the draining lymph node (LN). In this respect, the migration of antigen-
loaded dendritic cells (DCs) and recirculating lymphocytes has been extensively studied [reviewed 
by Girard et al. (1)].
Circulating monocytes are traditionally regarded as short-lived precursors of tissue mac-
rophages and monocyte-derived DCs (moDCs), recruited to tissues for supplementation of these 
cell populations during homeostasis and for expansion during inflammation (2, 3). The conventional 
Abbreviations: CCR2, CC-chemokine receptor 2; CX3CR1, CX3C-chemokine receptor 1; DCs, dendritic cells; FCM, flow 
cytometry; HE, hematoxylin and eosin staining; HEVs, high endothelial venules; IF, immunofluorescence; IHC, immunohis-
tochemistry; LN, lymph node; moDCs, monocyte-derived dendritic cells; PBMC, peripheral blood mononuclear cells; PPIA, 
peptidylprolyl isomerase A; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.
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view is that DCs rather than monocytes subsequently migrate 
from the inflamed tissues to LNs (1). However, monocytes 
display an array of pattern recognition receptors, which enables 
them to react to danger and pathogenic stimuli and produce 
cytokines, and recent studies indicate that monocytes may have 
distinct effector functions of their own, including the transport 
and presentation of antigen (4–9), functions that were previ-
ously designated to DCs only.
In humans, monocytes can be classified into subsets based on 
their expression of the lipopolysaccharide (LPS) receptor CD14 
and the FcγIIIR CD16 (10, 11). Classical monocytes are CD16-
negative and form the major population in blood. The minor 
CD16-positive monocyte population can be further subdivided 
into a CD14+ CD16++ non-classical subset and a third less 
well-defined CD14++ CD16+ intermediate subset, suggested to 
represent a transitional subset between the classical and non-
classical monocytes (12). Whereas the classical and intermediate 
subsets possess pro-inflammatory properties, the non-classical 
subset may serve a patrolling function (10, 13, 14). However, the 
precise roles of the different monocyte subsets, and in particular 
intermediate monocytes, are not well defined neither in the 
steady state nor under different inflammatory conditions. The 
most realistic approach to reach experimental evidence for such 
roles is in vivo animal studies. Circulating bovine monocytes have 
recently been described as phenotypically similar to humans, as 
the same three subsets based on CD14 and CD16 expression 
have been recognized in cattle (15–17). Thus, the use of the cow 
as an animal model may overcome some of the challenges of 
the large phenotypical differences between mouse and human 
monocytes (18).
The trafficking of monocytes is mediated by a multitude of 
chemokine receptors, and the different subsets show different 
receptor expression profiles. Especially the CC-chemokine recep-
tor 2 (CCR2) and the CX3C-chemokine receptor 1 (CX3CR1) can 
be applied to distinguish between different subsets in humans 
and mice (11, 19, 20). Human classical monocytes express high 
levels of CCR2 and low levels of CX3CR1 and are accordingly 
poised to traffic to sites of infection and inflammation, whereas 
non-classical monocytes have a high expression of CX3CR1 (19, 
21, 22). As an intermediate subset, CD14++ CD16+ monocytes 
most likely express both receptors. However, since the majority of 
studies on this topic refer to CD14+ versus CD16+ monocytes or 
to mouse monocyte subsets, this is not fully resolved. Adhesion 
molecules, such as L-selectin (CD62L) are also important in 
monocyte trafficking, enabling their adhesion to endothelium 
and transmigration into tissue.
The majority of studies describing phenotypical and functional 
characteristics of myeloid cells are based on in vitro differentiated 
blood-derived monocytes. The aim of this study was to charac-
terize the in vivo recruitment and activation of immune cells in 
inflamed tissue and the draining LN, using a bovine model. For 
this purpose, we used a saponin-based adjuvant, which has been 
shown to induce both humoral and cellular immunity (23), and 
an efficient induction of leukocyte recruitment to the draining LN 
of mice (24, 25). We show here that the induction of inflammation 
in calves resulted in a surprisingly potent recruitment of cells to 
the draining LN, dominated by CD14++ CD16+ monocytes. The 
migrating cells retained their monocytic character rather than 
differentiating into moDCs, and showed a high expression of 
genes coding for pro-inflammatory cytokines. Altogether, these 
results provide novel information on the phenotype and func-
tional capacity of monocytes after the onset of inflammation, and 
challenge the conventional view of monocyte trafficking in vivo.
MaTerials anD MeThODs
animals and experimental Design
Animals were clinically healthy Norwegian Red dairy (NRF) 
calves of both sexes, of 8–9 weeks of age, raised in commercial 
Norwegian dairy farms. The first trial included 14 animals dis-
tributed into four experimental groups and kept in separate pens: 
6 calves served as non-injected controls, whereas 8 calves were 
injected with 500 μg Matrix-Q™ (a kind gift from Novavax AB, 
Uppsala, Sweden). The adjuvant was suspended in 2  ml sterile 
Hanks’ balanced salt solution (Gibco, Life Technologies) prior to 
injection and administered as a single subcutaneous dose in the 
left posterior flank region, in an area drained by the subiliac LN. 
The contralateral skin and subiliac LN were untreated. A second 
trial included four new calves, which received the same treatment 
as in the first trial in addition to an injection with a 10-fold lower 
dose (50 μg) of Matrix-Q™ in the left neck region, in an area 
drained by the superficial cervical LN. The results presented 
herein refer to the first trial, unless otherwise stated.
Calves were given acidified milk or milk replacer, calf concen-
trate, water ad lib and access to straw, and the health status of the 
animals was examined twice daily. All experimental procedures 
were conducted in accordance with the laws and regulations 
controlling experiments using live animals in Norway: the 
Norwegian Animal Welfare Act of 28 December 2009 and the 
Norwegian Regulation on Animal Experimentation of 15 January 
1996. The study was approved by the Norwegian Animal Research 
Authority (Norwegian Food Safety Authority).
Tissue collection and Preparation
EDTA blood samples were collected prior to adjuvant injection 
(pre-injected samples), and from the experimental groups at 24 h 
(n = 3), 48 h (n = 3), and 96 h (n = 2) post-injection in the first 
trial, and at 24 h (n = 4) post-injection in the second trial. The 
96 h group was also sampled for blood at 72 h. Hematological dif-
ferential counting was performed on EDTA blood (Advia® 2120 
Hematology System, Siemens AG, Erlangen, Germany). Bovine 
peripheral blood mononuclear cells (PBMCs) were isolated by 
density gradient centrifugation (2210 × g, 30 min) on lymphoprep 
(Axis-Shield, Norway), and either analyzed immediately by flow 
cytometry (FCM), or added freezing medium (Recovery™ cell 
culture freezing medium, Gibco) for further storage in liquid 
nitrogen.
Subiliac LNs from calves in the non-injected controls (n = 6) 
were collected at a conventional slaughterhouse. Injected calves 
were stunned by a captive bolt pistol and exsanguinated, and 
subjected to post-mortem examination at the Norwegian 
University of Life Sciences. Samples in the first trial were col-
lected at 24, 48, and 96 h post-injection, and included the drain-
ing subiliac LN and the contralateral LN. In the second trial, 
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samples were collected at 24 h and also included the draining 
superficial cervical LN.
Skin with subcutaneous tissue and LNs on the injected side 
and the contralateral flank were collected and fixed for histology 
and immunohistochemistry (IHC). Formalin fixed samples were 
embedded in paraffin wax and prepared by standard procedures 
before staining with hematoxylin and eosin (HE) for light micros-
copy. Skin and LN specimens were frozen in chlorodifluorometh-
ane (Isceon™) chilled with liquid nitrogen, and stored at −70°C 
until further preparation.
Lymph nodes were excised vertically, and the anterior half 
toward the injection site was subjected to tissue preparation. 
LN tissue was minced mechanically by scissors in the presence 
of PBS/EDTA buffer. First, the LN cell suspensions were filtered 
through a Cell Strainer™ (BD Falcon), second, through a cotton 
filter pad soaked with PBS/EDTA, and finally washed in PBS/
EDTA before direct analysis or freezing as described above.
immunohistochemistry
Cryostat sections were cut 7  μm in thickness, mounted onto 
poly-lysine-coated slides and stored at −70°C before use. The 
sections were air dried at room temperature (RT), fixed in ice 
cold acetone, and finally rinsed and rehydrated in PBS pH 7.3. An 
indirect immunoperoxidase staining technique was performed 
on the sections by using an avidin–biotin complex method with 
the aid of a commercial kit (Vector Laboratories, Burlingame, CA, 
USA). To avoid non-specific binding of the biotinylated antibody, 
a blocking solution containing normal horse serum diluted 1:50 
in 5% BSA/TBS and avidin diluted 1:6 was applied to the sections 
for 20 min at RT. The blocking solution was carefully tapped off 
the slides. Antibodies diluted in 1% BSA/TBS were added to the 
slides and the slides incubated overnight at 4°C. The subsequent 
day, the slides were washed carefully in PBS 3 × 5 min, and bioti-
nylated horse anti-mouse IgG was diluted 1:100 in 1% BSA/TBS 
and added to the slides for 30 min at RT. The slides were washed 
carefully in PBS 3 × 5 min. Endogenous peroxidase was inhibited 
by treatment with 1% H2O2 in methanol for 15 min, followed by 
rinsing in PBS for 3 ×  5  min. The avidin–biotin–horse radish 
peroxidase complex solution was prepared at least 30 min prior 
to use, according to kit instructions. The sections were incubated 
with the complex solution for 30 min. All incubations were done 
in a slowly rotating humid chamber at RT. Peroxidase activity 
was visualized by incubation with Imm Pact AEC peroxidase 
substrate. The reaction was stopped by rinsing in PBS. Slides 
were counterstained with Mayer’s hematoxylin for 15 s, rinsed in 
PBS, and mounted. To control for non-specific binding, all runs 
included a control section where the primary antibodies were 
replaced by 1% BSA/TBS.
immunofluorescence
Immunofluorescent (IF) staining was performed essentially as 
previously described (26). Briefly, 7 μm cryostat sections were 
fixed in acetone and treated with 20% BSA/TBS in order to 
block non-specific binding. One of the following two mixtures 
of three primary antibodies were added to the sections: mouse 
anti-human CD14 (Tük4, IgG2a), mouse anti-bovine CD205 
(MCA1651G, IgG2b) (both AbD Serotec), and mouse anti-bovine 
CD11c (BAQ153A, IgM) (VMRD), or mouse anti-human CD14, 
mouse anti-ovine CD21 (DU2-74-25, IgG2b) (a kind gift from 
W. Hein), and polyclonal rabbit anti-ki67 (Abcam) all used at 
previously determined optimal dilutions. Secondary antibodies 
were isotype-specific Alexa Fluor (350, 594, and 488) (Molecular 
Probes, Inc., USA). All incubations were done in a slowly rotating 
humid chamber for 1 h at RT. Slides were mounted in polyvinyl 
alcohol and stored at 4°C until examination. Control sections 
were included, replacing the primary antibody with 1% BSA/TBS, 
and replacing the secondary antibody with an irrelevant antibody. 
All tissue sections were examined in a Carl Zeiss Axio Imager M2 
microscope equipped with a conventional camera (Axiocam HRc 
Rev. 3) and fluorescence camera (Axiocam HRm Rev. 3).
Flow cytometry
Flow cytometry analysis was performed on fresh or previously 
frozen LN cell suspensions or PBMCs. Cells were first stained 
with LIVE/DEAD® Fixable aqua or yellow dead cell stain kit 
(Invitrogen), following the manufacturer’s instructions. Primary 
unconjugated monoclonal antibodies applied in the current study 
were mouse anti-bovine and against the following molecules: 
CD14 (CAM36A, IgG1), CD3 (MM1A, IgG1), CD62L (BAQ92A, 
IgG1), granulocyte marker (CH138A, IgM), CD11b (MM12A, 
IgG1) (all Monoclonal Antibody Center, Washington State 
University, USA), anti-ovine CD21 (DU2-74-25, IgG2b), and 
mouse anti-bovine CD205 (MCA1651G, IgG2b) (AbD Serotec/
BioRad). Directly conjugated antibodies were cross-reactive 
anti-human CD16-FITC (KD1, IgG2a) and CD14-Pacific blue 
(Tük4, IgG2a) (both AbD Serotec/BioRad). Secondary isotype-
specific reagents were either PE-conjugated or APC-conjugated 
(Southern Biotech, Birmingham, USA), or Alexa Fluor 488-or 
647-conjugated (Molecular Probes/Life Technologies) polyclonal 
goat-anti-mouse antibodies, or PerCP- eFluor 710 conjugated 
rat anti-mouse monoclonal antibody (eBioscience/Affymetrix). 
All  antibodies were used at previously determined optimal 
concentrations. FCM was performed with a 3-laser Gallios 
flowcytometer (Beckman Coulter), and gating based on staining 
with secondary antibodies only or isotype controls. Data were 
analyzed using the Kaluza software (Beckman Coulter).
isolation of cD14+ cells and  
rT-qPcr analysis
Cell suspensions from the draining subiliac LNs collected at the 
second trial were used for isolation of CD14+ cells and RT-qPCR 
analysis. Cell suspensions were either snap frozen (n =  3) or 
used further for cell isolation (n =  4), as previously described 
(27). Briefly, CD14+ cells were extracted by positive selection of 
monocyte differentiation antigen CD14 using anti-human CD14 
MACS Microbeads (coated with mAb clone Tük4) (Miltenyi 
Biotec GmbH, Bergisch Gladbach, Germany), according to the 
manufacturer’s instructions. Purity of selected cells was verified 
by FCM, and was found to be in the range of 95–98%. Isolated 
CD14+ cells were snap frozen in liquid nitrogen and transferred 
to −70°C for further storage.
Peripheral blood mononuclear cells used for CD14+ baseline 
isolation were obtained from healthy NRF calves of 8–9 weeks 
of age (n = 3). Total RNA was isolated from LN cell suspensions 
TaBle 1 | list of primers used for reverse transcription-quantitative Pcr (rT-qPcr).
gene symbol, accession no. Primers (5′ → 3′) amp (bp) reference
CD14, NM_174008.1 CGATTTCCGTTGTGTCTGC 150 (16)
TACTGCTTCGGGTTGGTGT
CD16α, NM_001077402.1 Low-affinity FcγIIIR TGTCTCGTCATTCTTTCTACCTTG 138 (16)
ACTTTGCCATCCCTCCATTC
CX3CR1, NM_001102558.2 CX3C-chemokine receptor 1 TCACCAGAGAGAAAGAGAACGA 108 (16)
GGAGCAGGAAGCCAAGAAA
CCR2, NM_001194959 CC-chemokine receptor 2 GATGAAGAACCCACCACCAG 118 (16)
CAAAGATGAAGACCAGCGAGTAG
TGFβ1, NM_001166068.1 Transforming growth factor beta 1 CAATTCCTGGCGCTACCTCA 121 Primer 3
GCCCTCTATTTCCTCTCTGCG
IL-1β, NM_174093.1 Interleukin-1 beta AAAAATCCCTGGTGCTGGCT 89 Primer 3
CATGCAGAACACCACTTCTCG
IL-6, NM_173923.2 Interleukin-6 CCTGAAGCAAAAGATCGCAGA 97 Primer 3
TGCGTTCTTTACCCACTCGT
IL-10, NM_174088.1 Interleukin-10 TATCCACTTGCCAACCAGCC 152 Primer 3
GGCAACCCAGGTAACCCTTA
IL-12β, NM_174356.1 Interleukin-12 subunit beta GAGGTCGTGGTAGAAGCTGT 87 Primer 3
TGGGTCTGGTTTGATGATGTCC
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(6 × 106 cells), LN CD14+ cells (16 × 106 to 2.7 × 106 cells) and 
blood CD14+ baseline cells (6 × 106 cells), using the MirVANA 
isolation kit (Ambion, Austin, TX, USA) following the manufac-
turer’s instructions. All RNA samples were treated with amplifica-
tion grade DNase I (Invitrogen) to remove any traces of genomic 
DNA, and RNA concentration and quality was measured using 
NanoDrop 1000 (Thermo Fisher Scientific, Wilmington, USA) 
and 2100 BioAnalyzer (Agilent Technologies, Palo Alto, USA), 
respectively. All samples had a RNA integrity number (RIN) 
above 8.7 (except one where RIN = 6.6) and an OD A260/A280 
ratio of ≥2.0. A total of 200 ng of RNA was used for cDNA syn-
thesis reaction using Tetro cDNA synthesis kit (Nordic BioSite, 
Norway), and 10 ng was used in qPCR in triplicate per sample 
using Express SYBR GreenER SuperMix with premixed ROX 
(Invitrogen) according to the manufacturer’s recommendations. 
Transcript levels were analyzed using a 7900HT Fast Real-Time 
PCR System (Applied Biosystems) and the standard cycling 
program: 50°C for 2 min, 95°C for 2 min, 40 cycles of 95°C for 
15 s, and 60°C for 1 min, and the melting curve analyses were 
applied. Gene-specific primers were from either literature or 
designed using Primer3 ver. 0.4.0 (28). The transcript levels of the 
following genes were analyzed: CD14, CD16α, IL-1β, IL-6, TNFα, 
TGFβ, IL-12β, IL-10, CCR2, and CX3CR1. Primer sequences are 
presented in Table  1. The efficiencies of all primer pairs were 
tested by template dilution series using pooled cDNA from LN 
cells suspensions and CD14+ baseline cells and were 100% (±10). 
Negative controls with no added template were included for all 
primer pairs (no template control), and no RT control reactions 
for each sample and each primer pair were run in qPCR in order 
to check for genomic DNA contamination (no RT control). The 
peptidylprolyl isomerase A (PPIA) reference gene selected for 
the current study has been shown to be one of the most stable 
genes for gene expression studies in cattle macrophages (27) and 
lymphocytes (29), and in human LPS-stimulated monocytes (30). 
Initial analysis of the RT-qPCR data was performed using RQ 
Manager 1.2 (Applied Biosystems). Standard deviation of ≤0.3 
per triplicate was accepted. The ΔCt method was used to calculate 
RT-qPCR data, i.e., ΔCt = Cttarget gene − Ctreference gene, and normal-
ized gene expression was calculated as 2 (−ΔCt). Distribution of the 
data for the expression levels for each gene was tested by Shapiro–
Wilk’s normality test in R (R: A Language and Environment for 
Statistical Computing, ver. 3.2.4, The R Core Team, 2016). The 
differences of normalized gene expression levels between CD14+ 
baseline cells and CD14+ cells from LN for each gene were tested 
using either unpaired t-test (for normally distributed data) or the 
unpaired Wilcoxon rank-sum test (for non-normally distributed 
data) in GraphPad (GraphPad Prism version 7.00 for Windows, 
GraphPad Software). Statistical significance was assigned at 
P ≤ 0.05.
statistics
Flow cytometry data were analyzed in the JMP Pro 12 statistical 
software (SAS Institute). Differences between groups consisting 
of different individuals were assessed by the Wilcoxon rank-
sum test, and are indicated by *. Differences between groups 
consisting of the same individuals were assessed by the paired 
t-test, and are indicated by #. Statistical significance was assigned 
at P < 0.05.
resUlTs
adjuvant injection led to a strong 
recruitment of Monocytes
A saponin-based adjuvant was injected subcutaneously in the flank 
region of calves. Calves were euthanized at different time points 
following injection, and blood as well as tissues at the injection 
and contralateral sites, including skin, draining, and contralateral 
LNs, were subjected to pathological and immunological analyses. 
FigUre 1 | cellular recruitment to skin and subcutaneous tissues. (a) HE stained sections of skin with subcutaneous tissue from the side injected 
with adjuvant and the contralateral side, at 24 h post-injection. Scale bars: 200 μm. (B) Enlargement of outlined areas in A, as indicated. Scale bars: 20 μm. 
(c) Immunofluorescent labeling of subcutaneous tissue on the injected side with antibody against CD14 (green). Scale bar: 20 μm.
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On macroscopic evaluation, the injection site was characterized 
by a subcutaneous edema, and the draining LN was found to 
be two- to threefold enlarged (not shown). These changes were 
most pronounced at 24 h post-injection. Skin and LNs from the 
contralateral side did not show these changes.
Histopathological evaluation of the skin on the injected side 
revealed a diffuse, locally extensive, and moderate-to-severe 
inflammation in deeper cutaneous and subcutaneous tissues 
(Figure 1A), consisting of an infiltration of neutrophils, lympho-
cytes, and large monocyte-like cells (Figure  1B). A substantial 
amount of the inflammatory infiltrate consisted of CD14+ cells 
(Figure 1C).
Flow cytometry analysis of cells from the draining LN revealed 
a distinct appearance of numerous cells in the monocyte gate 
at 24 h post-injection, which were only scarcely present in the 
contralateral LN (Figures  2A,B). Also the relative percentage 
of cells in the granulocyte gate was increased, while the overall 
lymphocyte population was reduced at this time point. Detailed 
results are presented in Table S1 in Supplementary Material. IHC 
staining of the draining LN demonstrated that numerous CD14+ 
FigUre 2 | cellular recruitment to lymph nodes (ln) and peripheral blood. (a) LN cells were prepared for FCM analysis and gated on forward/side 
scatter (FSC/SSC) characteristics. Plots from one representative animal are presented. Panels illustrate the gating of lymphocytes, monocytes, and granulocytes 
as indicated and in the draining LN (left) and the contralateral LN (right), at 24 h post-injection. (B) Percentages of major immune cell populations in LNs, based 
on the gating strategy in A. Horizontal stacked bars show mean percentages of lymphocytes (gray), monocytes (dark gray), and granulocytes (black) of the total 
live cell population in non-injected animals (n = 6) and at different time points after adjuvant injection (n = 2–3). (c) IHC labeling of draining and contralateral LNs 
at 24 h post-injection with antibody against CD14. Different regions of the LN are indicated. (D) Cellular differential counts in peripheral blood. Horizontal stacked 
bars show mean absolute numbers (×109) of lymphocytes (gray), monocytes (dark gray), and granulocytes (black) at pre-injection and at different time points 
after adjuvant injection.
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cells were present in the subcapsular and peri-trabecular sinuses, 
and in the T-cell zones of the cortex (Figure 2C).
There was a marked and transient increase in the absolute 
number of granulocytes in peripheral blood, peaking at 24 h post-
injection, with a mean fold increase of 2.8 from pre-injected levels 
(Figure 2D). The increase in the absolute number of monocytes 
in blood was less evident and came later, peaking to a double level 
at 72 h post-injection. Detailed results are presented in Table S2 
in Supplementary Material.
recruited Monocytes Were cD14++ cD16+
Prior to adjuvant injection, monocytes from PBMC could be 
divided into three different subsets based on the expression of 
CD14 and CD16 (Figure 3A), coherent with previous reports (16, 
17). Monocytes recruited to the draining LNs at 24 h post-injection 
were of an essentially homogeneous CD14++ CD16+ phenotype 
(Figure  3B). Moreover, the intensity of CD14 expression on 
these LN monocytes was increased in comparison to monocytes 
from PBMC (Figure 3C). CD14++ cells from draining LNs were 
FigUre 3 | Phenotype of recruited monocytes. Density plots of live cells (upper panels) from PBMC pre-injection (a) and the draining LN at 24 h post-injection 
(B). Plots from one representative animal are presented. Monocytes were further gated into subsets based on their expression of CD14 and CD16 (lower panels). 
Isotype control for CD14 on live cells from LN is shown far right. (c) CD14 expression on cells from the monocyte gate [as gated in (a,B)]. Histograms show the 
isotype control for CD14 (light gray line), PBMC baseline (gray line), and draining LN at 24 h (black line). (D) CD11b expression and (e) CD62L expression on 
CD14++ cells. Histograms show the secondary Ab control (gray line) and the draining LN at 24 h (black line).
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FigUre 4 | Percentages of monocytes in lns and PBMc. (a) Percentages of CD14++ CD16+ monocytes of total live cells in LNs of non-injected animals, and 
in draining and contralateral LNs of injected animals at 24, 48, and 96 h post-injection. Symbols represent individual animals and the median value within each group 
is depicted as a line. Statistical significant differences between injected and non-injected groups using the Wilcoxon rank-sum test are indicated as *P < 0.05. 
Statistical significant differences between groups consisting of the same individuals (identical symbols) using the paired t-test are indicated as #P < 0.05. (B) 
Percentage of CD14+ monocytes of live cells in PBMC at pre-injection, and at 24, 48, 72, and 96 h post-injection. Symbols and statistics as in (a) (#P < 0.05). (c) 
Percentage of CD14++ CD16+ monocytes of live cells in the draining high dose (subiliac) LN and the contralateral LN, and in the draining low-dose (superficial 
cervical) LN. Symbols and statistics as in A (#P < 0.05). (D) Percentage of CD14+ monocytes of total live cells in PBMC at pre-injection and after 24 h. Symbols and 
statistics as in A.
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CD11b+ (Figure 3D) and CD62L+ (Figure 3E). Monocyte-gated 
cells did not express the granulocyte antigen (CH138A) or the 
T-cell marker CD3 in FCM, both confirmed to be present on cells 
in the respective granulocyte and lymphocyte gates (not shown).
Monocytes Were Transiently Present in the 
ln cortex and Migrated via the Medulla to 
Blood
Recruited CD14++ CD16+ cells constituted 20–41% of live cells in 
the draining subiliac LN 24 h after adjuvant injection (Figure 4A). 
In PBMC, CD14+ monocytes tended to increase in percentage 
later; measurably already at 24 h but apparently peaking in the 
two consecutive days (Figure 4B).
In the second trial, the recruitment of CD14++ CD16+ mono-
cytes to the draining subiliac LN was again demonstrated, but in 
lower numbers (Figure  4C). The second trial also included an 
injection of a 10-fold lower dose of adjuvant in the neck region, 
drained by the superficial cervical LN, leading to reduced recruit-
ment of monocytes. Like in the previous trial, an increase of CD14+ 
monocytes was demonstrated in blood after 24 h (Figure 4D).
The transient presence of monocytes in the draining LN was 
also visualized by IF staining. A high number of CD14+ cells were 
present in the draining LN at 24 h post-injection (Figure 5A), but 
not in the contralateral LN (Figure 5B). Monocytes did not express 
Ki67, indicating that they were not in active proliferation after entry 
to the LNs. After 48 h, monocytes had decreased in number in the 
cortex of the draining LN (Figure 5C), but were present in moderate 
to large amounts in the medulla, including the area around efferent 
lymph vessels (Figure 5D). In the second trial, a similar monocyte 
recruitment was observed to the LN cortex, but in lower numbers, 
whereas more monocytes were present in the medulla already at 
FigUre 5 | Distribution of monocytes in the lns. Immunofluorescent labeling of LNs with antibodies against CD14 (green), CD21 (blue), and Ki67 (red). CD21 
stains the LN follicles. (a) CD14+ cells were present in the capsule, subcapsular sinus, peri-trabecular sinus, and interfollicular areas of the draining LN at 24 h 
post-injection. (B) The contralateral LN was mainly devoid of CD14+ cells. Note the empty sub capsular sinus and trabecular sinus areas, as opposed to the 
infiltration in (a). (c) CD14+ cells were abundant in the capsule, but were decreased in numbers in the sinus and the cortex at 48 h post-injection. (D) CD14+ cells 
were present in the medulla of the LN at 48 h post-injection, and particularly around vessels. Follicle (f), interfollicular area (i), capsule (c), sinus area (s), vessel (v). 
Scale bars: 100 μm.
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24 h, indicating an earlier onset or a faster migration through the 
lymphoid tissue than observed in the first trial (not shown).
Taken together, these findings indicated that an adjuvant 
injection lead to a strong and transient recruitment of monocytes 
to the LN cortex, followed by migration into the medullary areas 
before departure via efferent vessels into the blood.
Monocytes in skin and Draining ln Did 
not express Dc-associated Markers
To investigate whether a differentiation of CD14+ cells toward 
a DC phenotype had taken place in subcutaneous tissues or in 
the draining LN, IF triple labeling of skin and LN tissue was 
performed with CD14 and the DC-associated markers CD205 
and CD11c. Numerous CD14+ monocytes were present in the 
deep cutis and subcutis on the injected side at 24 h post-injection 
(Figure 6A). A limited number of CD14− CD205+ cells were pre-
sent, possibly representing macrophages. Very few CD14+ cells 
were present in the skin on the non-injected side (Figure 6B). 
A moderate amount of CD11c+ CD205+ cells were observed in 
both the draining and the contralateral LN at 24 h post-injection, 
most likely representing conventional LN DCs (Figure 6C, insert, 
and Figure 6D). These cells did not triple label with the CD14-
marker. A minor proportion of CD14+ cells in the draining LN 
were found to be CD11c+, while none were CD205+. CD205 also 
labeled cells within the lymphoid follicles, as previously assigned 
to B cells in cattle (31). In FCM, CD14++ cells from the draining 
LN did not express CD205 (not shown).
Monocytes in the Draining ln expressed 
genes coding for Pro-inflammatory 
cytokines and CCR2
To investigate the functional capacity of recruited monocytes, 
CD14+ cells from the draining subiliac LNs of injected calves 
were isolated by positive selection and analyzed by RT-qPCR in 
the second trial. Baseline gene expression values were obtained 
from blood CD14+ cells isolated from calves of the same age 
and the same herd and were normalized to a housekeeping gene 
(PPIA). Expression levels of genes encoding for CD14, CD16α, 
IL-1β, IL-6, and TNFa were significantly higher in CD14+ 
cells from draining LNs compared to CD14+ cells from blood 
(P  ≤  0.05, Figures  7A,B). TGFβ also appeared upregulated, 
although the difference from baseline blood was non-significant 
FigUre 6 | Distribution of monocyte and Dc markers in skin and lns. Immunofluorescent labeling of subcutaneous tissues and LNs with antibodies against 
CD14 (green), CD205 (red) and CD11c (blue), at 24 h post-injection. (a) Large numbers of CD14+ cells were observed in the subcutis on the injected side. Note the 
separation of collagen bundles (appears as gray auto fluorescence, arrowheads) due to inflammatory infiltrates. A limited number of CD205+ cells were present. (B) 
A few CD14+ cells (arrow) were observed on the contralateral side. (c) CD14+ cells infiltrated the interfollicular areas of the cortex of the draining LN. A moderate 
amount of CD205+ CD11c+ DCs were observed (arrow heads in insert). (D) CD14+ cells were sparsely present in the contralateral LN. CD205+ follicles were 
surrounded by CD11c single labeled and CD11c+ CD205+ double labeled cells. Follicle (f), interfollicular area (i), capsule (c), sinus area (s). Scale bars: 100 μm.
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in this limited material. No clear difference in expression of 
IL-12β and IL-10 was found. Of the two chemokine receptors 
assessed, CCR2 gene expression level was higher in most CD14+ 
samples from injected animals, but not to a significant degree, 
likely due to an outlier in the baseline samples (Figure 7C). No 
difference in expression of the gene coding for the chemokine 
receptor CX3CR1 was found.
DiscUssiOn
While most studies of cell migration from inflamed tissues to 
draining LNs have focused on DCs (1), recent studies have shown 
that also monocytes travel via this route (4, 8, 9, 32). We here 
demonstrate a potent in  vivo recruitment of monocytes to the 
draining LN in a local acute inflammatory situation, and show 
that these cells upregulate genes for pro-inflammatory cytokines.
Recruited cells were of a uniformly CD14++ CD16+ phe-
notype and, thus, phenotypically resembled the intermediate 
monocyte subset described in humans (11, 20), and recently in 
cattle (16, 17). However, in contrast to bovine blood monocytes, 
we found that monocytes recruited in vivo to LNs stained more 
brightly for CD14 (CD14++). This phenotype was supported by 
RT-qPCR findings, showing a high gene expression for both 
CD14 and CD16α in these cells. CD14+ cells isolated from LNs 
had increased expression of genes associated with induction of 
inflammation, including TNFα, IL-1β, IL-6, and TGFβ. This is 
in line with other reports of intermediate monocytes expanding 
under different inflammatory conditions [reviewed by Italiani 
and Boraschi (33) and Ziegler-Heitbrock (34)], and strongly 
implicates a role for these CD14++ CD16+ monocytes in inflam-
matory processes in vivo.
Monocytes are believed to mainly differentiate into 
macrophages or moDCs in the inflamed tissue, after which 
predominantly moDCs will travel to the draining LN. These 
moDCs or “inflammatory” DCs should not be confused with 
conventional DCs that originate from an independent lineage of 
hematopoietic cells (35), and which have best been described in 
cattle in the afferent lymph (36–38). We found that the majority 
of CD14+ cells present in subcutaneous tissues and the draining 
LNs did not express the DC-associated markers CD205 and 
CD11c. Moreover, unlike moDCs, CD14++ cells were CD11b+ 
and CD62L+. The majority of studies of monocyte-derived 
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cells in cattle are based on in vitro generated cells from blood, 
which have been shown to downregulate CD14 and CD62L and 
upregulate CD205 (39–42). In mice, moDCs have been identified 
based on a high surface expression of CD11c (9, 43), whereas in 
humans CD11c is considered specific only for those DCs found 
in lymphoid organs (44, 45). In cattle, both blood monocytes 
and in vitro derived cells express CD11c, and the latter to a lesser 
degree than the former (16, 41, 42, 46). However, the in  vitro 
differentiation of blood monocytes cannot fully recapitulate the 
differentiation in vivo, which may be influenced by a combina-
tion of factors in the tissue environment, such as chemokines, 
cytokines, or administered adjuvant or antigen. Collectively, the 
overall phenotype indicates that the recruited cells in the present 
study labeling CD14++ CD16+ CD11b+ CD62L+ were monocytes 
rather than moDCs.
Monocytes were present in the skin and subcutaneous tissue at 
the injection site and in high numbers in the sinus and the T-cell 
area of the LN cortex. This is consistent with the possibility of a 
monocyte migration from the skin to the draining LN via affer-
ent lymph. Indeed, the presence of monocytes in afferent lymph 
of sheep (4, 47) and rat (32) has been described, and recently, 
adoptively transferred monocytes were shown to migrate from 
skin to the draining LN in mice (8, 9). We cannot exclude the 
possibility that monocytes also entered the LN from blood via 
high endothelial venules (HEVs), as CD14++ cells were strongly 
CD62L positive, and the recruitment of monocytes from blood 
across HEVs has been reported (48). However, the predominant 
route of monocyte trafficking to LNs is thought to be via the affer-
ent lymph (10, 43, 49). We also did not observe any monocytes 
increase in blood prior to their appearance in LNs. Moreover, we 
FigUre 7 | gene expression of monocytes from the draining ln. Gene expression levels (normalized to the reference gene PPIA) of CD14+ cells isolated from 
blood (baseline non-injected) and from the draining LN at 24 h post-injection, as analyzed by RT-qPCR. Symbols represent individual animals and the median value 
within each group is depicted as a line. Statistical significant differences between the two groups using the unpaired t-test (for normally distributed data) are 
indicated as #P ≤ 0.05, and the Wilcoxon rank-sum test (for non-normally distributed data) are indicated as *P ≤ 0.05. (a) Gene expression levels of CD14, CD16α, 
IL-1β, and TGFβ. (B) Gene expression levels of IL-12β, TNFα, IL-6, and IL-10. Note the difference in y-axis range from (a). (c) Gene expression levels of chemokine 
receptors CCR2 and CX3CR1. Note the difference in y-axis range from (a,B).
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